We are live on ! Find out more
ECP

Empyrean Capital Partners Portfolio holdings

AUM $3.07B
1-Year Est. Return 34.24%
This Fund
S&P 500
This Quarter Est. Return
+6.35%
1 Year Est. Return
+34.24%
3 Year Est. Return
+104.05%
5 Year Est. Return
+133.06%
10 Year Est. Return
+500.1%
AUM
$1.52B
AUM Growth
-$402M
Cap. Flow
-$654M
Cap. Flow %
-43.03%
Top 10 Hldgs %
64.47%
Holding
79
New
8
Increased
7
Reduced
10
Closed
22

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 19.32%
2 Healthcare 16.01%
3 Energy 9%
4 Materials 7.26%
5 Real Estate 6.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGN
1
DELISTED
Allergan plc
AGN
$243M 16.01%
1,273,500
SPY icon
2
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$166M 10.94%
+516,824
New +$159M
LOW icon
3
Lowe's Companies
LOW
$121B
$136M 8.92%
1,132,614
+259,856
+30% +$29.7M
SRG
4
Seritage Growth Properties
SRG
$138M
$100M 6.59%
2,500,000
HES
5
DELISTED
Hess
HES
$63.3M 4.16%
947,000
+25,000
+3% +$1.64M
MPC icon
6
Marathon Petroleum
MPC
$90.1B
$62.8M 4.13%
1,042,000
+717,000
+221% +$44.9M
WW
7
DELISTED
WW International
WW
$61.1M 4.02%
1,600,000
-497,846
-24% -$18.9M
EXP icon
8
Eagle Materials
EXP
$6.49B
$50.8M 3.34%
560,000
-452,343
-45% -$41.4M
HGV icon
9
Hilton Grand Vacations
HGV
$4.04B
$49.9M 3.28%
1,450,000
-669,468
-32% -$23M
PLYA
10
DELISTED
Playa Hotels & Resorts
PLYA
$47.2M 3.1%
5,615,000
SPY icon
11
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$45.1M 2.96%
140,000
-106,000
-43% -$32.6M
NG icon
12
NovaGold Resources
NG
$2.54B
$38.3M 2.52%
4,271,345
-265,405
-6% -$1.84M
TFSL icon
13
TFS Financial
TFSL
$5.11B
$35.2M 2.31%
1,788,868
LSXMK
14
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$31.9M 2.1%
869,209
VMC icon
15
Vulcan Materials
VMC
$36.8B
$21.3M 1.4%
+148,000
New +$21.2M
LSXMA
16
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$21.2M 1.39%
606,252
LTRPA
17
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$15.9M 1.05%
2,168,753
PCG icon
18
PG&E
PCG
$39B
$15.2M 1%
1,400,000
+552,000
+65% +$4.73M
LORL
19
DELISTED
Loral Space and Communications, Inc.
LORL
$13.7M 0.9%
424,279
-25,721
-6% -$943K
CURO
20
DELISTED
CURO Group Holdings Corp.
CURO
$13.3M 0.87%
1,091,166
-202,834
-16% -$2.71M
NXE icon
21
NexGen Energy
NXE
$5.91B
$10.8M 0.71%
8,435,700
-1,266,300
-13% -$1.63M
AMCIU
22
DELISTED
AMCI Acquisition Corp Unit
AMCIU
$10.4M 0.69%
+1,000,000
New +$10.4M
BMY.RT
23
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$6.43M 0.42%
+2,136,200
New +$5.55M
NOMD icon
24
Nomad Foods
NOMD
$1.77B
$5.44M 0.36%
+243,000
New +$4.95M
HFRO
25
Highland Opportunities and Income Fund
HFRO
$407M
$4.86M 0.32%
+391,304
New +$4.71M

Similar funds

Empyrean Capital Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Empyrean Capital Partners held 79 positions worth $1.52B, down 21% from $1.92B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Empyrean Capital Partners withdrew a net $654M in Q4 2019, closing 22 positions and reducing 10 holdings. Its most notable exit was Celgene Corp, an estimated $153M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Energy.

Against the trend, Empyrean Capital Partners opened a new position in State Street SPDR S&P 500 ETF Trust worth $166M.

  • Empyrean Capital Partners's largest Q4 2019 buy was State Street SPDR S&P 500 ETF Trust: 516,824 shares worth $166M.
  • Empyrean Capital Partners added most to Marathon Petroleum in Q4 2019, an estimated $44.9M increase.
  • Empyrean Capital Partners's biggest Q4 2019 reduction was Eagle Materials, cutting an estimated $41.4M.
  • Empyrean Capital Partners fully exited Celgene Corp in Q4 2019, selling an estimated $153M.
  • Empyrean Capital Partners's ten largest holdings make up 64% of its $1.52B portfolio in Q4 2019.
  • Empyrean Capital Partners opened 8 new positions and closed 22 in Q4 2019.
  • Empyrean Capital Partners's portfolio value fell 21% quarter-over-quarter to $1.52B.

Based on Empyrean Capital Partners's 13F filing for Q4 2019, filed 14 Feb 2020.